Grants per year
Personal profile
Education/Academic qualification
PhD, Shanghai Second Medical University
… → 1993
Fingerprint
Dive into the research topics where Bo Shi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 4 Finished
-
Dysregulated ciliogenesis in scleroderma: novel pathogenic mechanism?
Varga, J. & Shi, B.
Rheumatology Research Foundation
9/1/19 → 8/31/20
Project: Research project
-
Damage-Associated Molecular Patterns Driving Fibrosis Progression in Scleroderma
Varga, J., Bhattacharyya, S. & Shi, B.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
6/13/19 → 4/30/21
Project: Research project
-
Inhibition of CD38 NADase by anti-CD38 antibody: a novel therapy for systemic scleroderma
Varga, J. & Shi, B.
3/13/19 → 8/31/20
Project: Research project
-
Targeting NAD metabolism to treat systemic sclerosis
Varga, J. & Shi, B.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
9/18/18 → 8/31/20
Project: Research project
-
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis
Shi, B., Wang, W., Korman, B. D., Kai, L., Wang, Q., Wei, J., Bale, S., Goncalves Marangoni, R., Bhattacharyya, S., Miller, S., Xu, D., Akbarpour, M., Cheresh, P., Proccissi, D., Gursel, D., Espindola-Netto, J. M., Chini, C. C. S., de Oliveira, G. C., Gudjonsson, J. E., Chini, E. N. & 1 others, , Jan 22 2021, In: iScience. 24, 1, 101902.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis
Peclat, T. R., Shi, B., Varga, J. & Chini, E. N., Nov 1 2020, In: Current opinion in rheumatology. 32, 6, p. 488-496 9 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
The Primary Cilium: Emerging Role as a Key Player in Fibrosis
Teves, M. E., Strauss, J. F., Sapao, P., Shi, B. & Varga, J., Jun 1 2019, In: Current rheumatology reports. 21, 6, 29.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations -
Pharmacological inhibition of tolllike receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis
Bhattacharyya, S., Wang, W., Tamaki, Z., Shi, B., Yeldandi, A., Tsukimi, Y., Yamasaki, M. & Varga, J., Oct 23 2018, In: Frontiers in immunology. 9, OCT, 2434.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
The role of macrophages in the response to TNF inhibition in experimental arthritis
Huang, Q. Q., Birkett, R., Doyle, R., Shi, B., Roberts, E. L., Mao, Q. & Pope, R. M., Jan 1 2018, In: Journal of Immunology. 200, 1, p. 130-138 9 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations